Peter Vickerman
research-information.bris.ac.uk
0000-0002-8291-5890
Masaryk University
16 papers found
Refreshing results…
Impact and cost‐effectiveness of the national scale‐up of HIV pre‐exposure prophylaxis among female sex workers in South Africa: a modelling analysis
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya: a model‐based cost‐effectiveness analysis
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis
Cost‐effectiveness of screening and treatment using direct‐acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, Pakistan
Response to Commentary on Hancock et al . (2020): Low dead space syringes are just one component of an integrated package of care needed to tackle HCV and social exclusion among people who inject drugs
Prisons can also improve drug user health in the community
Cost‐effectiveness of the HepCATT intervention in specialist drug clinics to improve case‐finding and engagement with HCV treatment for people who inject drugs in England
Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation
Cost‐effectiveness of scaling‐up HCV prevention and treatment in the United States for people who inject drugs
Monitoring the hepatitis C epidemic in England and evaluating intervention scale‐up using routinely collected data
Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study
Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland
Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?
Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care (Preprint)
Scaling-up HCV prevention and treatment interventions in rural United States-model projections for tackling an increasing epidemic
Missing publications? Search for publications with a matching author name.